Jing Tu

Jing Tu is an accomplished professional in the fields of bioanalysis and corporate development, currently serving as Associate Director of BioPharm Bioanalysis CRO oversight at GSK since July 2024. Prior to this role, Jing held positions including Chief of Staff/Head of Corporate Development and Strategy at Resolian, where strategic counsel was provided to enhance organizational collaboration across global lab locations. Experience at AbbVie as Group Manager involved leading a Ligand Binding Assay team with successful project outcomes in oncology, immunology, and neurology. Previous roles at PPD included significant achievements in revenue growth and team expansion within the biomarker LBA group. Early career experience at Frontage Laboratories focused on method development for drug evaluation, while initial training included an internship at the Jilin Institute for Drug and Food Control. Jing holds an MBA from the Yale School of Management, a Bachelor of Medicine in Pharmaceutical Science from Jilin University, and an M.S. in Pharmaceutical Chemistry from the New Jersey Institute of Technology.